Showing results (351-360 of 1,319) with videos related to

Sort By:
Pageof 132
Journal of Inherited Metabolic Disease|November 20, 1998
The metabolism of phytanic acid and pristanic acid in man: a reviewN M Verhoeven, R J Wanders, B T Poll-The, et al.
Foods (Basel, Switzerland)|January 17, 2024
Satiating Capacity of Plant-Based Meat in Realistic Meal Contexts at HomeElizabeth H Zandstra, Ilse A Polet, Gertrude G Zeinstra, et al.
Human Mutation|June 30, 2000
A case of methemoglobinemia type II due to NADH-cytochrome b5 reductase deficiency: determination of the molecular basisC M Aalfs, G B Salieb-Beugelaar, R J Wanders, et al.
FEMS Microbiology Letters|May 23, 2002
Carnitine biosynthesis in Neurospora crassa: identification of a cDNA coding for epsilon-N-trimethyllysine hydroxylase and its functional expression in Saccharomyces cerevisiaeJan H Swiegers, Frédéric M Vaz, Isak S Pretorius, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 28, 2014
A systems biology analysis of the unique and overlapping transcriptional responses to caloric restriction and dietary methionine restriction in ratsSujoy Ghosh, Desiree Wanders, Kirsten P Stone, et al.
The Journal of Pediatrics|March 4, 2000
Carbohydrate-deficient glycoprotein syndrome type 1a: a variant phenotype with borderline cognitive dysfunction, cerebellar hypoplasia, and coagulation disturbancesC H van Ommen, M Peters, P G Barth, et al.
Bone Marrow Transplantation|March 21, 2017
Permanent diffuse alopecia after haematopoietic stem cell transplantation in childhoodD Bresters, D C M Wanders, M Louwerens, et al.
Diabetes|January 19, 2017
FGF21 Mediates the Thermogenic and Insulin-Sensitizing Effects of Dietary Methionine Restriction but Not Its Effects on Hepatic Lipid MetabolismDesiree Wanders, Laura A Forney, Kirsten P Stone, et al.
FEBS Letters|July 14, 1998
Involvement of microsomal fatty aldehyde dehydrogenase in the alpha-oxidation of phytanic acidN M Verhoeven, C Jakobs, G Carney, et al.
Investigational New Drugs|July 14, 2005
DE-310, a macromolecular prodrug of the topoisomerase-I-inhibitor exatecan (DX-8951), in patients with operable solid tumorsMoritz N Wente, Jörg Kleeff, Markus W Büchler, et al.
Pageof 132